Rare diseases
Investigational molecules
Locations
Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
FranceStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
FranceStudy of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer
FranceStudy on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
FranceStudy on Baricitinib for Treating Large Inflammatory Liver Adenomas in Women and Non-Resectable Cases in Men
FranceStudy of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial
FranceStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
FranceStudy of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma
FranceStudy of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery
FranceStudy of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery
FranceStudy of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy
FranceStudy Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
